In reviewHealthcare23 June 2026

Fortitude Mining Holdings, Inc. to acquire HeartSciences Inc.

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Fortitude Mining Holdings, Inc.
Target
HeartSciences Inc.
Deal value
Not disclosed
Announced
23 June 2026
Status
In review
Sector
Healthcare
Country
United States
Consideration
shares
What we know

Fortitude Mining Holdings, Inc. and HeartSciences Inc. have agreed to merge in a transaction structured as a merger of equals. Both companies are based in the United States and operate within the healthcare sector. The deal was announced on 23 June 2026. The consideration for the merger consists entirely of shares, with no cash component reported. The specific financial value of the transaction has not been disclosed by either party. As both entities are US-based, the merger does not involve cross-border regulatory complexities typically associated with international acquisitions. The combination aims to consolidate their respective positions in the healthcare market, although specific strategic rationales are not detailed in the available data. The transaction remains in the review phase, with no completion date currently established. Stakeholders are awaiting further regulatory developments before the deal can proceed to closing. The merger represents a significant structural change for both organizations, integrating their operations under a unified corporate framework. No additional financial terms or performance conditions have been made public at this stage.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update
  1. CMA invitation to comment

    Fortitude Mining Holdings, Inc. M&A filing involving HeartSciences Inc.

    Item 7.01. Regulation FD Disclosure. On October 6, 2026, HeartSciences Inc. (the “ Company ” or “ HeartSciences ”) issued a press release announcing that the U.S. Food and Drug Administration has granted 510(k) clearance (K260005) for the Company’s MyoVista® wavECG TM device as a 12-lead resting electrocardiograph, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K (th

    Source

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

Fortitude Mining Holdings, Inc.

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive